{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T02:40:02Z","timestamp":1742438402662,"version":"3.40.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ymgme.2024.108568","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T11:06:48Z","timestamp":1725707208000},"page":"108568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Base editing of the GLB1 gene is therapeutic in GM1 gangliosidosis patient-derived cells"],"prefix":"10.1016","volume":"143","author":[{"given":"Allisandra K.","family":"Rha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Hsin","family":"Kan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perla","family":"Andrade-Heckman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chloe L.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry F.","family":"Harb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2024.108568_bb0005","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.bbadis.2011.03.018","article-title":"GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings","volume":"1812","author":"Caciotti","year":"2011","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.ymgme.2024.108568_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.734878","article-title":"GM1 Gangliosidosis\u2014a mini-review","volume":"12","author":"Nicoli","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.ymgme.2024.108568_bb0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2147\/TACG.S206076","article-title":"GM1 Gangliosidosis: mechanisms and management","volume":"14","author":"AK","year":"2021","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.ymgme.2024.108568_bb0020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/257060a0","article-title":"Genetic heterogeneity in GM1-gangliosidosis","volume":"257","author":"Galjaard","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2024.108568_bb0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00005072-196901000-00003","article-title":"Chemical pathology of Gm1-gangliosidosis (generalized gangliosidosis)","volume":"28","author":"Suzuki","year":"1969","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymgme.2024.108568_bb0030","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ymgme.2008.04.012","article-title":"GM1 gangliosidosis: Review of clinical, molecular, and therapeutic aspects","author":"Brunetti-Pierri","year":"2008","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.ymgme.2024.108568_bb0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cccn.2004.11.035","article-title":"GM1-ganglioside degradation and biosynthesis in human and murine GM1-gangliosidosis","volume":"354","author":"Sano","year":"2005","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2024.108568_bb0040","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/humu.20147","article-title":"Role of \u03b2-galactosidase and elastin binding protein in lysosomal and nonlysosomal complexes of patients with GM1-gangliosidosis","volume":"25","author":"Caciotti","year":"2005","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2024.108568_bb0045","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/jhg.2009.70","article-title":"Structural bases of GM1 gangliosidosis and Morquio B disease","volume":"54","author":"Morita","year":"2009","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2024.108568_bb0050","article-title":"Characterization of glycan substrates accumulating in GM1 Gangliosidosis","volume":"21","author":"Lawrence","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2024.108568_bb0055","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ana.410090304","article-title":"GM1 Gangliosidosis: phenotypic variation in a single family","volume":"9","author":"Farrell","year":"1981","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2024.108568_bb0060","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1399-0004.2010.01379.x","article-title":"Phenotype determining alleles in GM1 gangliosidosis patients bearing novel GLB1 mutations","volume":"78","author":"Hofer","year":"2010","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2024.108568_bb0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.gene.2012.09.106","article-title":"Genotypic and phenotypic characterization of Brazilian patients with GM1 gangliosidosis","volume":"512","author":"Sperb","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.ymgme.2024.108568_bb0070","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/2281093b0","article-title":"GM1-gangliosidosis types 1 and 2: enzymatic differences in cultured fibroblasts","volume":"228","author":"Pinsky","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2024.108568_bb0075","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ymgme.2017.04.011","article-title":"Infantile gangliosidoses: mapping a timeline of clinical changes","volume":"121","author":"Jarnes Utz","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2024.108568_bb0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pediatrneurol.2013.02.003","article-title":"GM1 gangliosidosis, late infantile onset dystonia, and T2 hypointensity in the globus pallidus and substantia nigra","volume":"49","author":"Vieira","year":"2013","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2024.108568_bb0085","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ymgme.2019.12.012","article-title":"The natural history of type 1 infantile GM1 gangliosidosis: a literature-based meta-analysis","volume":"129","author":"Lang","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2024.108568_bb0090","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/jimd.12646","article-title":"Natural history of GM1 gangliosidosis\u2014retrospective cohort study of 61 French patients from 1998 to 2019","volume":"46","author":"Laur","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2024.108568_bb0095","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0022-3476(73)80438-X","article-title":"Gm1-gangliosidosis type I: in utero detection and fetal manifestations","volume":"82","author":"Kaback","year":"1973","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2024.108568_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1392683","article-title":"Therapeutic developments for neurodegenerative GM1 gangliosidosis","volume":"18","author":"Foster","year":"2024","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ymgme.2024.108568_bb0105","first-page":"649","article-title":"Animal model: feline GM1 gangliosidosis","volume":"74","author":"Baker","year":"1974","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymgme.2024.108568_bb0110","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0387-7604(01)00244-3","article-title":"Development of lysosomal storage in mice with targeted disruption of the \u03b2-galactosidase gene: a model of human GM1-gangliosidosis","volume":"23","author":"Itoh","year":"2001","journal-title":"Brain Dev."},{"key":"10.1016\/j.ymgme.2024.108568_bb0115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ymgme.2018.11.002","article-title":"Comprehensive behavioral and biochemical outcomes of novel murine models of GM1-gangliosidosis and Morquio syndrome type B","volume":"126","author":"Przybilla","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2024.108568_bb0120","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/hmg\/6.2.205","article-title":"Generalized CNS disease and massive G(M1)-ganglioside accumulation in mice defective in lysosomal acid \u03b2-galactosidase","volume":"6","author":"Hahn","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2024.108568_bb0125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1292\/jvms.65.213","article-title":"Clinical and clinico-pathologic characteristics of Shiba dogs with a deficiency of lysosomal acid \u03b2-galactosidase: a canine model of human GM1 gangliosidosis","volume":"65","author":"Yamato","year":"2003","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.ymgme.2024.108568_bb0130","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1939-1676.1994.tb03220.x","article-title":"Clinical and clinicopathologic characteristics of ovine GM-1 gangliosidosis","volume":"8","author":"Murnane","year":"1994","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.ymgme.2024.108568_bb0135","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1354\/vp.38-3-281","article-title":"GM1-gangliosidosis in Alaskan huskies: clinical and pathologic findings","volume":"38","author":"M\u00fcller","year":"2001","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.ymgme.2024.108568_bb0140","doi-asserted-by":"crossref","first-page":"R119","DOI":"10.1093\/hmg\/ddz127","article-title":"Large animal models contribute to the development of therapies for central and peripheral nervous system dysfunction in patients with lysosomal storage diseases","volume":"28","author":"Gurda","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2024.108568_bb0145","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2024.108568_bb0150","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nbt.3803","article-title":"Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions","volume":"35","author":"Kim","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymgme.2024.108568_bb0155","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2024.108568_bb0160","first-page":"379","article-title":"CRISPR Technology: A decade of genome editing is only the beginning","volume":"1979","author":"Wang","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2024.108568_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-20633-y","article-title":"CRISPR technologies and the search for the PAM-free nuclease","volume":"12","author":"Collias","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymgme.2024.108568_bb0170","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41587-020-0412-8","article-title":"Continuous evolution of SpCas9 variants compatible with non-G PAMs","volume":"38","author":"Miller","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"368","key":"10.1016\/j.ymgme.2024.108568_bb0175","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1126\/science.aba8853","article-title":"Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants","volume":"1979","author":"Walton","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2024.108568_bb0180","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1016\/j.ymthe.2021.09.002","article-title":"In vivo somatic cell base editing and prime editing","volume":"29","author":"Newby","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2024.108568_bb0185","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/crispr.2022.0045","article-title":"Gene editing corrects in vitro a G > a GLB1 transition from a GM1 Gangliosidosis patient","volume":"6","author":"Leclerc","year":"2023","journal-title":"CRISPR J."},{"key":"10.1016\/j.ymgme.2024.108568_bb0190","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/d41573-019-00139-z","article-title":"First in vivo CRISPR candidate enters the clinic","volume":"18","author":"Mullard","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymgme.2024.108568_bb0195","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2024.108568_bb0200","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2024.108568_bb0205","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41587-022-01326-x","article-title":"Base editing marches on the clinic","volume":"40","author":"Eisenstein","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymgme.2024.108568_bb0210","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq3010","article-title":"Phase 1 clinical trial of CRISPR-engineered CAR19 universal T cells for treatment of children with refractory B cell leukemia","volume":"14","author":"Ottaviano","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgme.2024.108568_bb0215","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/humu.9451","article-title":"Twenty-one novel mutations in the GLB1 gene identified in a large group of GM1-gangliosidosis and Morquio B patients: possible common origin for the prevalent p.R59H mutation among gypsies","volume":"27","author":"Santamaria","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2024.108568_bb0225","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/humu.9475","article-title":"GM1 gangliosidosis: molecular analysis of nine patients and development of an RT-PCR assay for GLB1 gene expression profiling","volume":"28","author":"Caciotti","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2024.108568_bb0230","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1399-0004.2007.00767.x","article-title":"Identification of 14 novel GLB1 mutations, including five deletions, in 19 patients with GM1 gangliosidosis from South America","volume":"71","author":"Santamaria","year":"2007","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2024.108568_bb0235","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.bbrc.2015.01.023","article-title":"Biochemical and molecular characterization of novel mutations in GLB1 and NEU1 in patient cells with lysosomal storage disorders","volume":"457","author":"Kwak","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2024.108568_bb0240","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/mgg3.527","article-title":"Clinical implementation of gene panel testing for lysosomal storage diseases","volume":"7","author":"Gheldof","year":"2019","journal-title":"Mol. Genet. Genomic Med."},{"year":"2024","series-title":"Deconvolution of Complex DNA Repair (DECODR): Establishing a Novel Deconvolution Algorithm for Comprehensive Analysis of CRISPR-Edited Sanger Sequencing Data","author":"Bloh","key":"10.1016\/j.ymgme.2024.108568_bb0245"},{"key":"10.1016\/j.ymgme.2024.108568_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102220","article-title":"Base editing rescues acid \u03b1-glucosidase function in infantile-onset Pompe disease patient-derived cells","volume":"35","author":"Christensen","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymgme.2024.108568_bb0255","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymgme.2024.108568_bb0260","series-title":"Cas-OFFinder: A Fast and Versatile Algorithm that Searches for Potential Off-target Sites of Cas9 RNA-guided Endonucleases","first-page":"1473","volume":"30","author":"Bae","year":"2014"},{"key":"10.1016\/j.ymgme.2024.108568_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005807","article-title":"A machine learning approach for predicting CRISPR-Cas9 cleavage efficiencies and patterns underlying its mechanism of action","volume":"13","author":"Abadi","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ymgme.2024.108568_bb0270","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","article-title":"CRISPResso2 provides accurate and rapid genome editing sequence analysis","volume":"37","author":"Clement","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymgme.2024.108568_bb0275","doi-asserted-by":"crossref","first-page":"W350","DOI":"10.1093\/nar\/gky300","article-title":"DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability","volume":"46","author":"Rodrigues","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymgme.2024.108568_bb0280","doi-asserted-by":"crossref","first-page":"10035","DOI":"10.1074\/jbc.275.14.10035","article-title":"Processing of lysosomal \u03b2-galactosidase","volume":"275","author":"van der Spoel","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2024.108568_bb0285","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10719-018-9818-7","article-title":"On the use of cholera toxin","volume":"35","author":"Chiricozzi","year":"2018","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.ymgme.2024.108568_bb0290","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/296651a0","article-title":"Non-coated membrane invaginations are involved in binding and internalization of cholera and tetanus toxins","volume":"296","author":"Montesano","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2024.108568_bb0295","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4081\/ejh.2010.e23","article-title":"Histochemical detection of GM1 ganglioside using cholera toxin-B subunit. Evaluation of critical factors optimal for in situ detection with special emphasis to acetone pre-extraction","volume":"54","author":"Petr","year":"2010","journal-title":"Eur. J. Histochem."},{"key":"10.1016\/j.ymgme.2024.108568_bb0300","article-title":"Intracerebroventricular enzyme replacement therapy with Beta-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice","author":"Chen","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2024.108568_bb0305","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11064-015-1742-7","article-title":"GM1 ganglioside is involved in epigenetic activation loci of neuronal cells","volume":"41","author":"Tsai","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ymgme.2024.108568_bb0310","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.3390\/ijms24119558","article-title":"Ganglioside GM1 and the central nervous system","volume":"24","author":"Guo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2024.108568_bb0315","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.653842","article-title":"Ganglioside GM1 targets astrocytes to stimulate cerebral energy metabolism","volume":"12","author":"Finsterwald","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymgme.2024.108568_bb0320","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1750-1172-8-114","article-title":"Galactosialidosis: review and analysis of CTSA gene mutations","volume":"8","author":"Caciotti","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2024.108568_bb0325","doi-asserted-by":"crossref","first-page":"28359","DOI":"10.1074\/jbc.271.45.28359","article-title":"Association of N-acetylgalactosamine-6-sulfate sulfatase with the multienzyme lysosomal complex of \u03b2-galactosidase, cathepsin a, and neuraminidase: possible implication for intralysosomal catabolism of keratan sulfate","volume":"271","author":"Pshezhetsky","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2024.108568_bb0330","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/emboj\/17.6.1588","article-title":"Transport of human lysosomal neuraminidase to mature lysosomes requires protective protein\/cathepsin A","volume":"17","author":"Van Der Spoel","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.ymgme.2024.108568_bb0335","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0022-3476(85)80472-8","article-title":"Cardiac involvement in diseases characterized by \u03b2-galactosidase deficiency","volume":"106","author":"Rosenberg","year":"1985","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2024.108568_bb0340","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nmeth.4278","article-title":"CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR\u2013Cas9 nuclease off-targets","volume":"14","author":"Tsai","year":"2017","journal-title":"Nature Methods"},{"key":"10.1016\/j.ymgme.2024.108568_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013468","article-title":"AAV-mediated gene delivery in adult GM1-gangliosidosis mice corrects lysosomal storage in CNS and improves survival","volume":"5","author":"Baek","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.ymgme.2024.108568_bb0350","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymgme.2024.108568_bb0355","first-page":"4353","article-title":"Systemic AAV9 Gene Transfer in Adult GM1 Gangliosidosis Mice Reduces Lysosomal Storage in CNS and Extends Lifespan","volume":"24","author":"Weismann","year":"2015"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224004529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224004529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T02:21:03Z","timestamp":1742437263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719224004529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":70,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1096719224004529"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108568","relation":{},"ISSN":["1096-7192"],"issn-type":[{"type":"print","value":"1096-7192"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Base editing of the GLB1 gene is therapeutic in GM1 gangliosidosis patient-derived cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108568"}}